SMLR: Semler Scientific EV/EBITDA Multiple

Corporate emblem and logo of Semler Scientific (SMLR)

The asset value for Semler Scientific, Inc. (SMLR) tracked on the GURU.Markets chart is 0.00, which correlates with sales of mature artery diagnostic systems and cryptocurrency investments. The business relies on patent protection and the complexities of physician retraining, which create market barriers. Furthermore, high crisis resilience is coupled with low seasonality dependence, although treasury policy increases overall volatility.

Semler - SMLR Enterprise Value to EBITDA Ratio (period 11/23/2025 - 01/31/2026)

Summary analytical data breakdowns for semlerscientific.com (SMLR)

- stock price and consensus target price:
Stock Quotes Semler Scientific Corp|SMLR - Analyst Forecast Prices
- market capitalization information:
Market Capitalization Semler|SMLR - Company Buyout Price
- issuer book value statistics:
Book Value per Share Semler Scientific|SMLR - Company Net Assets|Market Cap to Net Assets Ratio semlerscientific.com|SMLR - Aggregate Asset Value
- company liabilities and liquidity data:
Debt to Equity Semler Scientific, Inc.|SMLR - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Semler Scientific|SMLR - Company Cumulative Debt|Debts to Book Capitalization Semler|SMLR - Company Long-Term Indebtedness|Company Short-Term Debts Semler Scientific|Quick Ratio semlerscientific.com
- financial results and valuation multiples details:
SMLR - Net Income|Projected Future Earnings Semler Scientific, Inc.|SMLR - P/E Multiple|Future Price to Earnings Semler Scientific, Inc.|SMLR - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Semler|SMLR - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Semler Scientific|SMLR - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months semlerscientific.com|SMLR - Net earnings per share change in current year|Expected earnings per share growth for next year Semler Scientific, Inc.
Initial company analysis:Semler Scientific Corp SMLR
Original product of semlerscientific.com

The EV/EBITDA multiple determines the total enterprise value, including net debt, relative to its operating profit before taxes and amortization. A decrease in this ratio signals that the asset is undervalued, while an increase indicates overheated market expectations. By analyzing the dynamics of the core EV/EBITDA multiple, an investor assesses the efficiency of capital expenditures. For Semler Scientific, Inc. (SMLR), this is critical when implementing high-tech robotic assembly lines and AI-driven quality control.

Competitor analysis for Semler Scientific, Inc.

Abbott Laboratories Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio TMO (Thermo Scientific)|GE HealthCare - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio mt.com MTD|WAT: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Bio-Techne Corp|Enterprise Value to EBITDA Ratio BRKR|AZTA: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Varex Imaging (VREX)|Enterprise Value to EBITDA Ratio butterflynetwork.com BFLY|EV/EBITDA Multiple MLAB (Mesa Labs)|Quantum-Si Inc. (QSI) - Company Value to EBITDA|Nanox - EV/EBITDA Multiple|QTRX (Quanterix Inc) - Enterprise Value to Operating Income Before Depreciation|MASS: EV/EBITDA Multiple|CV - Total Company Value to Operating Income Before Depreciation Ratio|MXCT (MaxCyte) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Rapid Micro (RPID)|EV/EBITDA Multiple SEER|EV/EBITDA Multiple Hyperfine Medical (HYPR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization FONAR Corporation FONR|Daxor Corp - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MDAI: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation VIVS (Organovo Holdings)|ACON: EV/EBITDA Multiple|Company Value to EBITDA Akoya Biosciences, Inc. (AKYA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ThermoGenesis|TLIS - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio TTOO (T2 Biosystems)